EUVIMEDEUVIMED entdecken
Open Access

Returning Incidental Research Findings From 18 F ‐Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography to Participants: A Survey of Investigators From a Clinical Trial of Rheumatoid Arthritis

Jane S Kang iD, Howard F Andrews, Jon T Giles iD, Katherine P Liao iD, Daniel H Solomon iD, Joan M Bathon iD

Arthritis Care & Research · 2024-12 · 76 (12) · 1637-1646

DOI: 10.1002/acr.25424 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis Care & Research, online erschienen am 15.10.2024. Verfasst von Jane S Kang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Columbia University Medical Center, New York, New York. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Incidental Findings, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

There are limited data on researchers’ attitudes and beliefs on returning and managing incidental research findings from whole body 18 F‐fluorodeoxyglucose–positron emission tomography/computed tomography (FDG PET/CT) imaging.

Methods

Site principal investigators (PIs) who enrolled participants for the Treatments Against Rheumatoid Arthritis and Effect on FDG PET/CT (TARGET) trial were surveyed.

Results

Of the 28 TARGET site PIs eligible for the study, 18 consented to participate (response rate: 64%). Many site PIs returned incidental findings to participants (61%), and the most common finding that was returned was serious (but not life‐threatening) and treatable (54.5%). More than half of the investigators believed that adequacy of clinical follow up (58.8%) and legal liability if incidental findings are not disclosed (55.6%) were extremely important factors in returning incidental research findings from whole body FDG PET/CT. All investigators felt very obligated to return incidental research findings if scans revealed a treatable, high‐risk medical condition. Most investigators felt very obligated to disclose incidental findings with important health implications (94.4%), for which proven preventive or therapeutic interventions exist (77.8%), that provide early detection of a health problem (72.2%), if participants ask for their incidental findings (72.2%), and if scans have established validity for a particular medical condition (61.1%).

Conclusion

Although it is recommended that researchers report and manage incidental research findings, our data show differing views and uncertainties on what and how to return, and the extent of follow up needed to manage, incidental findings from whole body FDG PET/CT; this highlights the need for more specific and standardized guidance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidIncidental FindingsFluorodeoxyglucose F18Positron Emission Tomography Computed TomographyHumansRadiopharmaceuticalsResearch PersonnelSurveys and QuestionnairesFemaleMaleDisclosureAttitude of Health PersonnelWhole Body Imaging

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Columbia University Medical Center, New York, New York.
  • Cedars-Sinai Medical Center, Los Angeles, California.
  • Brigham and Women's Hospital, Boston, Massachusetts.

ORCID-Profile: Jane S Kang, Jon T Giles, Katherine P Liao, Daniel H Solomon, Joan M Bathon

Förderung

  • NIAMS NIH HHS
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Kang, J. S., Andrews, H. F., Giles, J. T., Liao, K. P., Solomon, D. H., & Bathon, J. M. (2024). Returning Incidental Research Findings From 18 F ‐Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography to Participants: A Survey of Investigators From a Clinical Trial of Rheumatoid Arthritis. Arthritis Care & Research, 76(12), 1637-1646. https://doi.org/10.1002/acr.25424

Vancouver

Kang JS, Andrews HF, Giles JT, Liao KP, Solomon DH, Bathon JM. Returning Incidental Research Findings From 18 F ‐Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography to Participants: A Survey of Investigators From a Clinical Trial of Rheumatoid Arthritis. Arthritis Care & Research. 2024;76(12):1637-1646. doi:10.1002/acr.25424

BibTeX
@article{Kang2024,
  author = {Kang, Jane S and Andrews, Howard F and Giles, Jon T and Liao, Katherine P and Solomon, Daniel H and Bathon, Joan M},
  title = {Returning Incidental Research Findings From 18 F ‐Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography to Participants: A Survey of Investigators From a Clinical Trial of Rheumatoid Arthritis},
  journal = {Arthritis Care & Research},
  year = {2024},
  volume = {76},
  number = {12},
  pages = {1637--1646},
  doi = {10.1002/acr.25424}
}
Kostenlos starten →